What are analysts'1 year price targets for Portola Pharmaceuticals (Port) stock?
7 equities research analysts have issued 1 year price targets for Portola Pharmaceuticals' stock. Their predictions range from $35.00 to $45.00. On average, they expect Portola Pharmaceuticals' stock price to reach $40.83 in the next twelve months.
How much is a share of Portola worth?
One share of PTLA stock can currently be purchased for approximately $18.03. How much money does Portola Pharmaceuticals make? Portola Pharmaceuticals has a market capitalization of $1.42 billion and generates $116.64 million in revenue each year.
How much of Portola Pharmaceuticals'stock is owned by institutions?
98.68% of the stock of Portola Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Portola Pharmaceuticals are expected to grow in the coming year, from ($2.46) to ($2.18) per share.
Where can I buy shares of ptlo?
Shares of PTLO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
See more
How were Portola Pharmaceuticals' earnings last quarter?
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) posted its quarterly earnings data on Monday, May, 11th. The biopharmaceutical company reported ($0.88)...
Who are Portola Pharmaceuticals' key executives?
Portola Pharmaceuticals' management team includes the following people: Ms. Mardi C. Dier , Exec. VP, Chief Bus. Officer & CFO (Age 55) Dr. John...
Who are some of Portola Pharmaceuticals' key competitors?
Some companies that are related to Portola Pharmaceuticals include Hypera (HYPMY) , Perrigo (PRGO) , Intra-Cellular Therapies (ITCI) , Acerus P...
What other stocks do shareholders of Portola Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Portola Pharmaceuticals investors own include Lexicon Phar...
What is Portola Pharmaceuticals' stock symbol?
Portola Pharmaceuticals trades on the NASDAQ under the ticker symbol "PTLA."
What is Portola Pharmaceuticals' stock price today?
One share of PTLA stock can currently be purchased for approximately $18.03.
How much money does Portola Pharmaceuticals make?
Portola Pharmaceuticals (NASDAQ:PTLA) has a market capitalization of $1.42 billion and generates $116.64 million in revenue each year. The biopharm...
How many employees does Portola Pharmaceuticals have?
Portola Pharmaceuticals employs 324 workers across the globe.
What is Portola Pharmaceuticals' official website?
The official website for Portola Pharmaceuticals is www.portola.com .
What is Portola Pharmaceuticals' stock symbol?
Portola Pharmaceuticals trades on the NASDAQ under the ticker symbol "PTLA."
Where are Portola Pharmaceuticals' headquarters?
Portola Pharmaceuticals is headquartered at 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA, 94080.
What is MarketBeat community ratings?
MarketBeat's community ratings are surveys of what our community members think about Portola Pharmaceuticals and other stocks. Vote “Outperform” if you believe PTLA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PTLA will underperform the S&P 500 over the long term. You may vote once every thirty days.
How much does Portola Pharmaceuticals make?
How much money does Portola Pharmaceuticals make? Portola Pharmaceuticals has a market capitalization of $1.42 billion and generates $116.64 million in revenue each year. The biopharmaceutical company earns $-290,660,000.00 in net income (profit) each year or ($4.06) on an earnings per share basis.
What is Portola Pharmaceuticals?
Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes novel therapeutics in the areas of thrombosis and other hematologic disorders and inflammation in the United States. The company offers Andexxa, an antidote for patients treated with rivaroxaban and apixaban when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding; and Bevyxxa (betrixaban), an oral, once-daily Factor Xa inhibitor for the prevention of venous thromboembolism in adult patients hospitalized for an acute medical illness. It is also advancing cerdulatinib, a dual spleen tyrosine kinase and janus kinases inhibitor in development for the treatment of hematologic cancers. In addition, the company is developing PRT2761, a Syk inhibitor that has completed Phase II clinical trial for the treatment for allergic conjunctivitis. Portola Pharmaceuticals, Inc. has collaboration agreements with Bristol-Myers Squibb; Pfizer Inc.; Bayer Pharma, AG; Janssen Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Millennium Pharmaceuticals, Inc.; SRX Cardio; LLC; Ora; and Astellas Pharma Inc. The company was founded in 2003 and is headquartered in South San Francisco, California.
Does Portola Pharmaceuticals pay dividends?
Portola Pharmaceuticals does not currently pay a dividend.
PTLA Target Price
PTLA price target in 14 days: 18.212 USD* upside and 17.901 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Portola Pharmaceuticals, Inc. ( PTLA ) Stock Market info
Recommendations: Buy or sell Portola Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Portola Pharmaceuticals share forecasts, stock quote and buy / sell signals below.
Emerald Advisers, Llc Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals ..
Investment company Emerald Advisers, Llc (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, HireRight Holdings Corp, Arhaus Inc, sells Chegg Inc, ORIC Pharmaceuticals Inc, BellRing Brands Inc, Trex Co Inc, Arena Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Advisers, Llc..
Emerald Mutual Fund Advisers Trust Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA ..
Leola, PA, based Investment company Emerald Mutual Fund Advisers Trust (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, Karuna Therapeutics Inc, HireRight Holdings Corp, sells Chegg Inc, BellRing Brands Inc, Echo Global Logistics Inc, Tetra Tech Inc, ORIC Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Mutual Fund Advisers Trust..
About Portillos
Portillo's Inc. provide fast-casual restaurant concept known for its menu of Chicago-style favorites. Portillo's Inc. is based in CHICAGO.
Headlines
Portillo's Holdings, LLC. -- Moody's announces completion of a periodic review of ratings of Portillo's Holdings, LLC. - Yahoo Finance
Portillos (NASDAQ:PTLO) Frequently Asked Questions
9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Portillos in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Portillos stock. View analyst ratings for Portillos or view top-rated stocks.
